Migdal Insurance & Financial Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-2,539
| Closed | -$1.31M | – | 657 |
|
2020
Q3 | $1.31M | Sell |
2,539
-2,201
| -46% | -$1.13M | 0.02% | 249 |
|
2020
Q2 | $2.14M | Buy |
4,740
+1,547
| +48% | +$698K | 0.03% | 174 |
|
2020
Q1 | $1.12M | Sell |
3,193
-852
| -21% | -$299K | 0.03% | 163 |
|
2019
Q4 | $1.5M | Buy |
4,045
+561
| +16% | +$208K | 0.03% | 171 |
|
2019
Q3 | $1.16M | Buy |
3,484
+1,042
| +43% | +$347K | 0.02% | 230 |
|
2019
Q2 | $763K | Buy |
2,442
+708
| +41% | +$221K | 0.02% | 271 |
|
2019
Q1 | $530K | Buy |
1,734
+1,035
| +148% | +$316K | 0.01% | 290 |
|
2018
Q4 | $162K | Buy |
+699
| New | +$162K | ﹤0.01% | 403 |
|